317 related articles for article (PubMed ID: 19448113)
21. Differentiation of renal cell carcinoma subtypes through MRI-based radiomics analysis.
Wang W; Cao K; Jin S; Zhu X; Ding J; Peng W
Eur Radiol; 2020 Oct; 30(10):5738-5747. PubMed ID: 32367419
[TBL] [Abstract][Full Text] [Related]
22. VHL and FHIT locus loss of heterozygosity is common in all renal cancer morphotypes but differs in pattern and prognostic significance.
Velickovic M; Delahunt B; Störkel S; Grebem SK
Cancer Res; 2001 Jun; 61(12):4815-9. PubMed ID: 11406557
[TBL] [Abstract][Full Text] [Related]
23. Papillary vs clear cell renal cell carcinoma. Differentiation and grading by iodine concentration using DECT-correlation with microvascular density.
Marcon J; Graser A; Horst D; Casuscelli J; Spek A; Stief CG; Reiser MF; Rübenthaler J; Buchner A; Staehler M
Eur Radiol; 2020 Jan; 30(1):1-10. PubMed ID: 31278580
[TBL] [Abstract][Full Text] [Related]
24. Papillary renal cell carcinoma in contrast-enhanced ultrasound (CEUS) - A diagnostic performance study.
Mueller-Peltzer K; Negrao de Figueiredo G; Graf T; Rübenthaler J; Clevert DA
Clin Hemorheol Microcirc; 2019; 71(2):159-164. PubMed ID: 30562896
[TBL] [Abstract][Full Text] [Related]
25. Low enhancing papillary renal cell carcinoma diagnosed by using dual energy computerized tomography: a case report and review of literature.
Alanee S; Dynda DI; Hemmer P; Schwartz B
BMC Urol; 2014 Dec; 14():102. PubMed ID: 25524502
[TBL] [Abstract][Full Text] [Related]
26. [Ipsilateral adrenalectomy is not obligatory in nephrectomy for renal cell carcinoma].
Aliaev IuG; Akhvlediani ND; Blokhin PS
Urologiia; 2008; (2):16-22. PubMed ID: 18574876
[TBL] [Abstract][Full Text] [Related]
27. [Differentiation of subtypes of renal cell carcinoma by double-phase helical computed tomography].
Dai JR; Zhang LY; Zhang J; Chen Y; Zhang HT; Jiang LX; Lin M
Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(31):2177-81. PubMed ID: 21029656
[TBL] [Abstract][Full Text] [Related]
28. Dismantling papillary renal cell carcinoma classification: The heterogeneity of genetic profiles suggests several independent diseases.
Marsaud A; Dadone B; Ambrosetti D; Baudoin C; Chamorey E; Rouleau E; Lefol C; Roussel JF; Fabas T; Cristofari G; Carpentier X; Michiels JF; Amiel J; Pedeutour F
Genes Chromosomes Cancer; 2015 Jun; 54(6):369-82. PubMed ID: 25820192
[TBL] [Abstract][Full Text] [Related]
29. A comparison of radiologic tumor volume and pathologic tumor volume in renal cell carcinoma (RCC).
Choi SM; Choi DK; Kim TH; Jeong BC; Seo SI; Jeon SS; Lee HM; Choi HY; Jeon HG
PLoS One; 2015; 10(3):e0122019. PubMed ID: 25799553
[TBL] [Abstract][Full Text] [Related]
30. Transitional cell and clear cell renal carcinoma: differentiation of distinct histological types with multiphase CT.
Bata P; Tarnoki DL; Tarnoki AD; Novak PK; Gyebnar J; Kekesi D; Szendroi A; Fejer B; Szasz AM; Nyirady P; Karlinger K; Berczi V
Acta Radiol; 2014 Nov; 55(9):1112-9. PubMed ID: 24243889
[TBL] [Abstract][Full Text] [Related]
31. Analysis of CT, MRI imaging features of renal cell carcinoma with different histopathological types.
Wang X; Kong W; Wang Y; Wang Y; Chen Y; Shi Z; Liu Y
J BUON; 2021; 26(5):2053-2058. PubMed ID: 34761616
[TBL] [Abstract][Full Text] [Related]
32. Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic disease.
Wagener N; Edelmann D; Benner A; Zigeuner R; Borgmann H; Wolff I; Krabbe LM; Musquera M; Dell'Oglio P; Capitanio U; Klatte T; Cindolo L; May M; Brookman-May SD;
PLoS One; 2017; 12(9):e0184173. PubMed ID: 28934212
[TBL] [Abstract][Full Text] [Related]
33. Chromophobe renal cell carcinoma in Iceland: an epidemiological and clinicopathological study.
Ingimarsson JP; Hardarson S; Petursdottir V; Jonsson E; Einarsson GV; Gudbjartsson T
Scand J Urol Nephrol; 2011 Nov; 45(5):306-11. PubMed ID: 21619417
[TBL] [Abstract][Full Text] [Related]
34. Clinico-radio-pathologic features of a solitary solid renal mass at MDCT examination.
Kim EY; Park BK; Kim CK; Lee HM
Acta Radiol; 2010 Dec; 51(10):1143-8. PubMed ID: 20849320
[TBL] [Abstract][Full Text] [Related]
35. Tumours in end-stage kidney.
Hora M; Hes O; Reischig T; Urge T; Klecka J; Ferda J; Michal M; Eret V
Transplant Proc; 2008 Dec; 40(10):3354-8. PubMed ID: 19100388
[TBL] [Abstract][Full Text] [Related]
36. Differential diagnosis of chromophobe renal cell carcinoma and papillary renal cell carcinoma with dual-energy spectral computed tomography.
Wang D; Huang X; Bai L; Zhang X; Wei J; Zhou J
Acta Radiol; 2020 Nov; 61(11):1562-1569. PubMed ID: 32088966
[TBL] [Abstract][Full Text] [Related]
37. Rupture of papillary renal cell carcinoma.
Hora M; Hes O; Klecka J; Boudová L; Chudácek Z; Kreuzberg B; Michal M
Scand J Urol Nephrol; 2004; 38(6):481-4. PubMed ID: 15841782
[TBL] [Abstract][Full Text] [Related]
38. [Comparative analysis of modern combined methods in diagnosis of renal cell carcinoma].
Teodorovich OV; Ternovoĭ SK; Vlasova IS; Zabrodina NB; Fominykh EV; Kesov IaE
Urologiia; 2006; (5):3-6, 11. PubMed ID: 17444144
[TBL] [Abstract][Full Text] [Related]
39. Multicentric papillary and chromophobe renal cell carcinomas in a patient with autosomal dominant polycystic kidney disease: Report of a rare case.
Sahoo N; Patra S; Senapati S; Mishra TS
Indian J Pathol Microbiol; 2017; 60(3):405-408. PubMed ID: 28937383
[TBL] [Abstract][Full Text] [Related]
40. [Radiologic diagnosis as a component of staging and surgical approach in carcinoma of the renal parenchyma].
Kaprin AD; Khudiashev SA; Shchetinin VV
Vopr Onkol; 2009; 55(5):594-7. PubMed ID: 20020655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
